The Fashionable Briefcase Is Made Out Of Bamboo or Mahogany and Comes With Many Exclusive Features

LOS ANGELES, CA / ACCESSWIRE / April 28, 2016 / The Companion: Finest Briefcase for Men is proud to announce its official launch.

Created by Christian Goossens and Tobias Kobmann, the use of wood in a briefcase was inspired by its appearance in a variety of fashion verticals including sunglasses, watches, and cell phone covers. Having never been crafted into a men’s carrying case before, bamboo seemed like an elegant and stylish alternative to the mass produced black briefcases that currently dominate the market.

With their idea in hand, the team created their company called Nisantari, and produced their first prototype briefcase in December of 2015. After months of hard work, they finally came up with their final product in February of this year.

According to initial client feedback, the final product is the next step in the evolution of briefcase style and function. “This is for the creatives, the CEOs, the managers; A compliment to every person mastering the daily life of business. Leave a lasting impression on people you meet, by choosing the finest briefcase for men,” says the website.

In addition to the sleek bamboo exterior, The Companion’s interior features a rawhide smartphone pocket, 3 pen holders, passport holder, cable storage, document holder, 4 credit card slots, and foam wedging for laptops (either one size fits all, or customizable). Other features include brushed silver hinges, leather straps to hold the briefcase open, a leather handle, and most importantly, a lock with a personal security code.

Countless prototype designs finally lead to a briefcase that was as thin and light as possible, weighing in at 3.5 pounds and having a thickness of 90mm. The case meets all airport regulations, and the team at Nisantari is offering new clients the opportunity to customize their briefcase in any way they’d like; the most popular options being custom embossing and company logos.

In order to mitigate some of the costs associated with producing The Companion briefcase, the team at Nistantari have taken their project to Kickstarter where they hope to raise the funds necessary to deliver it to a wider audience.

To learn more, please visit: https://goo.gl/ESSc0b.

About The Companion Briefcase for men:

The Companion was created by Christian Goossens and Tobias Kobmann and it is reportedly the first wooden briefcase of its type ever produced. Made from bamboo, and with a mahogany option, the briefcase comes with a wide variety of features tailored towards the stylish businessman on the go. The team has taken their creation to crowd funding in order to offset some of the financial strain endured by producing the world’s finest wooden briefcase.

Contact:

Rickey Knight
admin@rocketfactor.com
(949) 555-2861

SOURCE: The Companion Briefcase

ReleaseID: 439341

Chapter 7™ announces club membership for unique, rare whiskies delivered to member’s homes direct from the bottler

LOS ANGELES, CA / ACCESSWIRE / April 28, 2016 / Chapter 7™ announced today the opening of their club membership where connoisseurs of single malt whisky can receive access to the Swiss bottler’s exclusive whisky anthology. Created by Selim Evin, Chapter 7™ is an award winning distillery that produces whisky from barrels sourced from independent bottlers.

Evin was originally inspired by his Scottish grandfather’s passion for whisky and created his brand in 2014. He was taught at an early age that casks (barrels) give the whisky its own character and story. Using individual casks from Scotland and Ireland, each issue offers a distinct flavor and spirit that is unique unto itself.

“The wood, the previous content, age, temperature, location in the warehouse… Everything makes a difference,” says Evin. “Two casks of a distillery filled at the same time and sitting next to each other can taste different because the wood crafts its magic over the years in a subtly distinctive way.”

In modern distilleries, many casks are mixed together and then fine-tuned by a master blender to maintain a consistent taste; but according to Evin, this practice strips whisky of its soul, and bottling from singular barrels delivers a higher quality spirit that is far more agreeable to discerning pallets.

“Our whisky anthology offers an opportunity to experience the distinctiveness of each cask. Most of the time we bottle our whiskies at cask strength and we do not use chill-filtering to keep all of the characteristics of the whisky untouched,” says Evin.

Chapter 7™ has received numerous honors including Silver Medal at C2C Cup in Germany and the highly coveted Whisky Bible 2016 Liquid Gold Award.

In order to bring his brand to a wider audience, Evin has taken Chapter 7™ to Indiegogo where he hopes to raise the funds necessary to offer worldwide membership. He maintains over 7,000 Facebook followers and eager buyers, but until he can resolve the issue of international distribution, Chapter 7™ is relegated to serving their current pool of loyal whisky enthusiasts.

To learn more, please visit: https://goo.gl/yL71iU.

About Chapter 7™:

Chapter 7™ is an award winning Swiss independent bottler created by Selim Evin. Specializing in single malt whisky, Chapter 7™ sources high quality barrels from independent distilleries and bottles batches from single barrels. Each bottle is numbered and comes with a story of its creation.

Contact:

Patricia Willis
admin@rocketfactor.com
(949) 555-2861

SOURCE: Chapter 7™

ReleaseID: 439339

NEW YORK, NY / ACCESSWIRE / April 28, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Textura Corporation (NYSE: TXTR) stock prior to April 28, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Textura to Oracle for $26.00 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/textura or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 439344

NEW YORK, NY / ACCESSWIRE / April 28, 2016 / The Stock Expert is issuing a report on four stocks that are performing well this Thursday. SRPT, AEZS, ADMS and PACD are on high volume alert. Continue reading to find out why. – To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) The company is a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases.

Shares of SRPT are trading higher today by over 19% after a recent media reported suggested that the company can still secure approval for its DMD treatment despite being down voted earlier.

The surprise news has bolstered the stock, which is trading off heavier than usual volume after the piece of news was released.

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Aeterna Zentaris Inc. (NASDAQ: AEZS) Is a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health.

Shares of AEZS are trading higher by over 6% this morning after announcing that it acquired exclusive US promotional rights to Apifiny prostate cancer blood test pursuant to a new co-marketing agreement with Armune BioScience.

Share are already trading 2 times its average volume after making the announcement just after market close yesterday.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) Is a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems.

The company announced today that its Phase 3 trial (EASE LID 3) evaluating ADS-5102 (amantadine HCl) extended-release capsules for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease met its primary and key secondary endpoints.

However, the stock is not acting positively to the news and is trading lower by 6%.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

Pacific Drilling S.A. (NYSE: PACD) Together with its subsidiaries, operates as an offshore drilling contractor. It provides offshore drilling services to the oil and natural gas industry.

Shares of PACD are trading higher today by over 18%, continuing on the gains it has been making all week this week. The stock is also receiving a major boost in volume.

However, with an RSI (relative strength index) of over 78, the stock is trading in highly overbought levels and could be due for small pull back.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About TheStockExpert.com

The Stock Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “STOCKEXPERT”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The Stock Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The Stock Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit TheStockExpert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The Stock Expert
info@thestockexpert.com

SOURCE: The Stock Expert

ReleaseID: 439340

NEW YORK, NY / ACCESSWIRE / April 28, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased St. Jude Medical Inc. (NYSE: STJ) stock prior to April 28, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of St. Jude Medical to Abbott for $46.75 in cash and 0.8708 shares of Abbott common stock per St. Jude Medical share; this represents a value of approximately $85 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/stjudemedical or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 439342

SILVERDALE, WA / ACCESSWIRE / April 28, 2016 / CGrowth Capital, Inc. (OTC Pink: CGRA) (the “Company”) is pleased to update shareholders on the progress of its corporate initiatives and projects. Having recently received its initial subscriptions from its wholly owned subsidiary, CGrowth Capital Bond, Ltd., via the £15,000,000.00 British Pounds Sterling (“GBP”) bond offering, the Company has been undergoing changes and taking the necessary steps to properly deploy its capital.

In deploying the bond funds, the Company’s wholly owned subsidiary, Powder River Resources, Inc., has begun a series of strategic hires and equipment purchases to begin mobilizing in the 3,400-acre oil and gas project in Wyoming. Coming out of historically low oil prices and being in a position with capital, we are able to capitalize on deeply discounted equipment and the availability of highly qualified oil field personnel, in moving Powder River into a profitable enterprise. The Company is beginning to bring online an initial series of wells (up to 12) with another dozen being evaluated for workover and production. The first well brought back online after the winter shut in, known as the 182H (seen on our Facebook page), produced an initial push of 61 barrels of oil in its first 18 hours of operation.

The Company’s real estate holdings, known as Chewelah Properties, LLC, has previously announced a series of lucrative leases to legalized cannabis producer/processors at its Washington state facility. Chewelah Properties has completed the 21-day appeals period on its SEPA approval without further comment, cementing the approval for the F-1 manufacturing facility for legalized cannabis production and processing. In addition, the facility has in hand its required building permits for its tenant, Wildfire Cannabis Company, and is anticipating final inspection upon a few minor items being wrapped up. In conjunction with the permitting, Wildfire has informed the Company that they are submitted for State inspection and are awaiting notification from the Eastern Washington LCB inspector of the final inspection and the activation of approved active license status.

As part of an effort to rebrand and bring current information to its shareholders, the Company is releasing a new version of its website at http://www.CGrowthCapital.com. The site will provide information on the Company’s projects and initiatives, up to date shareholder information, and current news from the Company. The new site is expected to go live before close of business Friday at its current web address.

About CGrowth Capital, Inc.:

CGrowth Capital, Inc. The Company continues to serve as a holding company for businesses and assets focused on all aspects of mining, minerals, exploration, and commercial real estate. The processing of metal ore mining, mineral and specialty rock extraction, as well as oil and gas production, are multi-billion dollar market opportunities which is capitalized on through processing, sales, contracting and licensing of assets. CGrowth Capital’s services and solutions are designed to assist land owners with monetizing undervalued assets by bringing commodities such as gold, silver, oil and gas, and other commodities to market. CGrowth Capital will focus on acquiring or land assets, while also providing partners and affiliates with management services, capital, contract management and logistical services necessary for the successful execution of operations.

For more information about CGrowth Capital, visit their website: http://www.CGrowthCapital.com
https://www.facebook.com/CGrowthCapital
http://www.CGrowthCapitalBond.com

Investor Inquiries:

CGrowth Capital, Inc.
360-536-4500

Safe Harbor

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties. The Company disclaims any obligation to update or revise any forward-looking statements.

SOURCE: CGrowth Capital, Inc.

ReleaseID: 439338